A unique pharmaceutical company
Orphan Europe, part of the Recordati group, is a unique pharmaceutical company focusing on the research and development of orphan medicinal products. Since 1990 we have used big thinking and extensive know-how on behalf of people affected by rare diseases. Patients and their families are central to our planning, our thinking and our actions. Recordati orphan drugs is present in the USA through its company Recordati Rare Diseases.
News and events
EURORDIS Awards 2014
for outstanding accomplishments in the field of rare diseases presented in honour of Rare Disease Day in Brussels
Rare Disease Day is an annual, awareness-raising event co-ordinated by EURORDIS at the international level and by National Alliances and Patient Organisations at the national level.
Find more information on Rare Disease Day website
What did Orphan Europe do on Rare Disease Day?
In Russia, Orphan Europe took part in a roundtable "Accessibility of medical care and social support for patients with rare diseases in Russia" held in Moscow, we were involved in the scientific conference “Medical and social issues of orphan diseases: diagnosis, treatment, prevention” in Tomsk and a roundtable on patients with rare diseases “Rare but Equal" in St Petersburg In Greece we sponsored their national rare disease day*
And much more…